Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis

Oncotarget

Volumn 6, Issue 11, 2015, Pages 8525-8538

  Casimiro, Mathew C ^a,c   Di Sante, Gabriele ^a,c   Crosariol, Marco ^a,c   Loro, Emanuele ^a,c   Dampier, William ^d   Ertel, Adam ^a,c   Yu, Zuoren ^a,c   Saria, Elizabeth A ^e   Papanikolaou, Alexandros ^e   Li, Zhiping ^a,c   Wang, Chenguang ^a,c   Addya, Sankar ^a,c   Lisanti, Michael P ^a,c   Fortina, Paolo ^a,c   Cardiff, Robert D ^f   Tozeren, Aydin ^d   Knudsen, Erik S ^a,c   Arnold, Andrew ^e   Pestell, Richard G ^a,b,c,g  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d DREXEL UNIVERSITY   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Breast cancer; Chromosomal instability; Cyclin D1

Indexed keywords

CYCLIN D1; CCND1 PROTEIN, HUMAN; CCND1 PROTEIN, MOUSE; HYBRID PROTEIN; PALBOCICLIB; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOME; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION PROFILING; IMMUNOFLUORESCENCE; KARYOTYPE; KINETICS; MAMMARY GLAND; MICROARRAY ANALYSIS; MITOSIS SPINDLE; MOUSE; MUTANT; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING; WILD TYPE; ADENOCARCINOMA; AMINO ACID SUBSTITUTION; ANIMAL; CELL CULTURE; CELL TRANSFORMATION; CENTROSOME; DEFICIENCY; ENZYME ACTIVE SITE; EXPERIMENTAL MAMMARY NEOPLASM; GENETIC TRANSDUCTION; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE MAMMARY TUMOR VIRUS; MUTATION; PHYSIOLOGY; PROTO ONCOGENE; SPINDLE APPARATUS; ULTRASTRUCTURE;

ADENOCARCINOMA; AMINO ACID SUBSTITUTION; ANEUPLOIDY; ANIMALS; CATALYTIC DOMAIN; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CENTROSOME; CHROMOSOMAL INSTABILITY; CYCLIN D1; FEMALE; FIBROBLASTS; GENES, BCL-1; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; PIPERAZINES; PYRIDINES; RECOMBINANT FUSION PROTEINS; SPINDLE APPARATUS; TRANSDUCTION, GENETIC;

EID: 84928753090     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3267     Document Type: Article

References (52)

1. Arnold A, Papanikolaou A. Cyclin d1 in breast cancer pathogenesis. Journal of Clinical Oncology. 2005; 23:4215-4224.
2. Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991; 350:512-515.
3. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994; 369:669-671.
4. Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Modern Pathology. 1995; 8:560-567.
5. Nielsen NH, Loden M, Cajander J, Emdin SO, Landberg G. G1-S transition defects occur in most breast cancers and predict outcome. Breast Cancer Research and Treatment. 1999; 56:105-112.
6. Jares P, Rey MJ, Fernandez PL, Campo E, Nadal A, Munoz M, Mallofre C, Muntane J, Nayach I, Estape J, et al. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status. Journal of Pathology. 1997; 182:160-166.
7. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Knudsen ES. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. Journal Biological Chemistry. 2003; 278:30339-30347.
8. Lu F, Gladden AB, Diehl JA. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Research. 2003; 63:7056-7061.
9. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes and Development. 2004; 18:2699-2711.
10. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes and Development. 1993; 7:331-342.
11. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 1993; 73:487-497.
12. Sakamaki T, Casimiro MC, Ju X, Quong AA, Katiyar S, Liu M, Jiao X, Li A, Zhang X, Lu Y, et al. Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol. 2006; 26:5449-5469.
13. Wang C, Li Z, Lu Y, Du R, Katiyar S, Yang J, Fu M, Leader JE, Quong A, Novikoff PM, et al. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Natl Acad Sci U S A. 2006; 103:11567-11572.
14. Jeselsohn R, Brown NE, Arendt L, Klebba I, Hu MG, Kuperwasser C, Hinds PW. Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell. 2010; 17:65-76.
15. Albanese C, D'Amico M, Reutens AT, Fu M, Watanabe G, Lee RJ, Kitsis RN, Henglein B, Avantaggiati M, Somasundaram K, et al. Activation of the cyclin D1 gene by the E1A-associated protein p300 through AP-1 inhibits cellular apoptosis. Journal of Biological Chemistry. 1999; 274:34186-34195.
16. Li Z, Wang C, Jiao X, Katiyar S, Casimiro MC, Prendergast GC, Powell MJ, Pestell RG. Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration. The Journal of Biological Chemistry. 2008; 283:7007-7015.
17. Neumeister P, Pixley FJ, Xiong Y, Xie H, Wu K, Ashton A, Cammer M, Chan A, Symons M, Stanley ER, et al. Cyclin D1 governs adhesion and motility of macrophages. Molecular Biology of the Cell. 2003; 14:2005-2015.
18. Jirawatnotai S, Hu Y, Michowski W, Elias JE, Becks L, Bienvenu F, Zagozdzon A, Goswami T, Wang YE, Clark AB, et al. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature. 2011; 474:230-234.
19. Hulit J, Wang C, Li Z, Albanese C, Rao M, Di Vizio D, Shah S, Byers SW, Mahmood R, Augenlicht LH, et al. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Molecular and Cellular Biology. 2004; 24:7598-7611.
20. Fu M, Wang C, Rao M, Wu X, Bouras T, Zhang X, Li Z, Jiao X, Yang J, Li A, et al. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. The Journal of Biological Chemistry. 2005; 280:29728-29742.
21. Bienvenu F, Jirawatnotai S, Elias JE, Meyer CA, Mizeracka K, Marson A, Frampton GM, Cole MF, Odom DT, Odajima J, et al. Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen. Nature. 2010; 463:374-378.
22. Casimiro MC, Crosariol M, Loro E, Ertel A, Yu Z, Dampier W, Saria EA, Papanikolaou A, Stanek TJ, Li Z, et al. ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice. The Journal of Clinical Investigation. 2012; 122:833-843.
23. Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Current Biology. 2010; 20:R285-295.
24. Gordon DJ, Resio B, Pellman D. Causes, consequences of aneuploidy in cancer. Nature Reviews Genetics. 2012; 13:189-203.
25. Gollin SM. Mechanisms leading to chromosomal instability. Seminars in Cancer Biology. 2005; 15:33-42.
26. Draviam VM, Xie S, Sorger PK. Chromosome segregation and genomic stability. Current Opinions in Genetics Development. 2004; 14:120-125.
27. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proceedings of the National Academy of Sciences. USA. 1994; 91:709-713.
28. Baker GL, Landis MW, Hinds PW. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation. Cell Cycle. 2005; 4:330-338.
29. Landis MW, Pawlyk BS, Li T, Sicinski P, Hinds PW. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell. 2006; 9:13-22.
30. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nature Genetics. 2006; 38:1043-1048.
31. Fu M, Rao M, Bouras T, Wang C, Wu K, Zhang X, Li Z, Yao TP and Pestell RG. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. The Journal of Biological Chemistry. 2005; 280:16934-16941.
32. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A. The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocrine Reviews. 1999; 20:501-534.
33. Zwijsen RM, Buckle RS, Hijmans EM, Loomans CJ, Bernards R. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Development. 1998; 12:3488-3498.
34. Fu M, Wang C, Li Z, Sakamaki T, Pestell RG. Minireview: Cyclin D1: Normal and Abnormal Functions. Endocrinology. 2004; 145:5439-5447.
35. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP and Pestell RG. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proceedings of the National Academy of Sciences USA. 2010; 107:8231-8236.
36. Oyama T, Kashiwabara K, Yoshimoto K, Arnold A and Koerner F. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Research. 1998; 58:2876-2880.
37. Shoker BS, Jarvis C, Davies MP, Iqbal M, Sibson DR and Sloane JP. Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. British Journal of Cancer. 2001; 84:1064-1069.
38. Yu Q, Sicinska E, Geng Y, Ahnstrom M, Zagozdzon A, Kong Y, Gardner H, Kiyokawa H, Harris LN, Stal O, et al. Requirement for CDK4 kinase function in breast cancer. Cancer Cell. 2006; 9:23-32.
39. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A and Pestell RG. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. The Journal of Biological Chemistry. 1995; 270:23589-23597.
40. Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GK, 3rd, Webster M, Muller WJ, Brugge JS, Davis RJ, et al. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signalregulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription factor-2 in pp60(v-src) signaling in breast cancer cells. The Journal of Biological Chemistry. 1999; 274:7341-7350.
41. Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines GK, 3rd, Siegel PM, Hung MC, Yarden Y, et al. Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway. Molecular and Cellular Biology. 2000; 20:672-683.
42. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE, Jr. Stat3 as an oncogene. Cell. 1999; 98:295-303.
43. Stahl M, Ge C, Shi S, Pestell RG and Stanley P. Notch1-induced transformation of RKE-1 cells requires up-regulation of cyclin D1. Cancer Research. 2006; 66:7562-7570.
44. Joyce D, Bouzahzah B, Fu M, Albanese C, D'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, et al. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway. The Journal of Biological Chemistry. 1999; 274:25245-25249.
45. Casimiro MC, Velasco-Velazquez M, Aguirre-Alvarado C and Pestell RG. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present. Expert Opinion on Investigational Drugs. 2014; 23:295-304.
46. Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Ju X, et al. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Molecular and Cell Biology. 2006; 26:4240-4256.
47. Kuhn RM, Haussler D and Kent WJ. The UCSC genome browser and associated tools. Briefings in Bioinformatics. 2013; 14:144-161.
48. Taylor J, Schenck I, Blankenberg D and Nekrutenko A. Using galaxy to perform large-scale interactive data analyses. Current Protocols in Bioinformatics. 2007; Chapter 10:Unit 10 15.
49. Portales-Casamar E, Thongjuea S, Kwon AT, Arenillas D, Zhao X, Valen E, Yusuf D, Lenhard B, Wasserman WW and Sandelin A. JASPAR 2010: the greatly expanded openaccess database of transcription factor binding profiles. Nucleic Acids Research. 2010; 38:D105-110.
50. Tuteja G, White P, Schug J and Kaestner KH. Extracting transcription factor targets from ChIP-Seq data. Nucleic Acids Research. 2009; 37:e113.
51. Silverman BW. (1986). Density Estimation for Statistics and Data Analysis. (London: Chapman and Hall).
52. Wu K, Jiao X, Li Z, Katiyar S, Casimiro MC, Yang W, Zhang Q, Willmarth NE, Chepelev I, Crosariol M, et al. Cell fate determination factor Dachshund reprograms breast cancer stem cell function. The Journal of Biological Chemistry. 2011; 286:2132-2142.